image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 0.2461
-3.83 %
$ 23.6 M
Market Cap
0.02
P/E
BALANCE SHEET
214 M ASSETS
-30.28%
118 M LIABILITIES
103.51%
96.2 M EQUITY
-61.44%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Bionano Genomics, Inc.
image
Current Assets 140 M
Cash & Short-Term Investments 102 M
Receivables 9.66 M
Other Current Assets 28.6 M
Non-Current Assets 74.3 M
Long-Term Investments 400 K
PP&E 32.5 M
Other Non-Current Assets 41.4 M
Current Liabilities 100 M
Accounts Payable 10.4 M
Short-Term Debt 72.2 M
Other Current Liabilities 17.4 M
Non-Current Liabilities 18.2 M
Long-Term Debt 7.18 M
Other Non-Current Liabilities 11 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 17.9 5.1 24.6 38.4 17.3 16.5 1.0 5.2
Short Term Investments 48.8 108.1 226.0 0 0 0 0 0
Receivables 9.7 7.0 4.9 2.8 6.3 4.5 3.4 1.8
Inventory 22.9 29.8 12.4 3.3 3.4 1.1 1.7 1.8
Other Current Assets 5.7 7.3 4.5 1.1 0.8 0.9 1.1 1.8
Total Current Assets 140.1 157.3 272.4 46.8 28.3 23.0 7.1 10.7
PP&E 32.5 29.0 20.9 4.9 1.9 1.8 3.0 4.1
Intangible Assets 34.0 41.1 26.8 1.5 0 0 0 0
Goodwill 0 77.3 56.2 7.2 0 0 0 0
Long Term Investments 0.4 0.4 0 0 0 0 0 0
Other Long Term Assets 7.4 2.8 0.7 0.1 (1.9) 0 0 0
Other Assets 0 0 0 0 0 0 0 0
Total Assets 214.4 307.5 377.1 60.4 30.2 24.8 10.1 14.8
LIABILITIES
Accounts Payable 10.4 12.5 9.7 2.9 2.7 1.4 2.3 0.8
Short Term Debt 72.2 5.1 3.5 0 20.1 0 6.7 0.6
Other Current Liabilities 16.3 17.4 7.9 5.0 3.2 2.9 7.4 7.5
Total Current Liabilities 100.0 35.9 21.8 8.9 26.3 4.5 16.7 9.4
Long Term Debt 7.2 9.1 8.9 16.3 0 9.0 0 (19.4)
Deferred Tax Income 0 0 0 97.9 K 0 0 0 25.4
Other Liabilities 10.9 13.0 9.1 0 0.2 0.8 43.6 (24.4)
Total Liabilities 118.2 58.1 40.0 25.4 26.6 14.7 60.4 42.0
EQUITY
Common Stock 5 K 30 K 29 K 19 K 3.43 K 1 K 8 7
Retained Earnings (581.2) (348.7) (216.1) (143.7) (102.6) (72.8) (54.3) (30.9)
Other Accumulative Comprehensive Income/Loss 23 K (1.1) (0.5) 0 0 (5.2) (3.9) (2.4)
Total Equity 96.2 249.4 337.1 35.1 3.6 10.1 (50.2) (27.3)
Total Liabilities and Equity 214.4 307.5 377.1 60.4 30.3 24.8 10.1 14.8
SHARES OUTSTANDING
Common Shares Outstanding 34.1 28.9 27.7 10.4 1.5 0.7 0.3 0.5